Выбор редакции

Roche To Top $66 Billion In Sales By 2020, Led By Neuroscience

Roche Holding’s revenue grew at a CAGR of 5.3% from $52.5 billion in 2015 to $64.4 billion in 2019, and it is estimated to top $66 billion in 2020, led by its Neuroscience drugs. The company’s oncology drugs will account for 45% of the company’s total sales in 2020, but Neuroscience drugs are key...
НОВОСТИ ПО ТЕМЕ